ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 312 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $32,836,857 | +9.4% | 1,263,442 | +20.4% | 0.01% | +20.0% |
| Q1 2024 | $30,016,815 | -7.6% | 1,049,539 | -1.2% | 0.01% | -16.7% |
| Q4 2023 | $32,496,190 | +169.4% | 1,061,967 | +136.6% | 0.01% | +100.0% |
| Q3 2023 | $12,061,943 | -47.2% | 448,900 | -30.0% | 0.00% | -40.0% |
| Q2 2023 | $22,861,127 | +26.3% | 641,086 | -10.0% | 0.01% | +25.0% |
| Q1 2023 | $18,099,812 | -40.4% | 712,591 | -4.8% | 0.00% | -42.9% |
| Q4 2022 | $30,365,365 | +89682.6% | 748,653 | -26.8% | 0.01% | -22.2% |
| Q3 2022 | $33,821 | -1.6% | 1,023,321 | +4.8% | 0.01% | 0.0% |
| Q2 2022 | $34,385 | -99.9% | 976,584 | +24.5% | 0.01% | +12.5% |
| Q1 2022 | $36,085,000 | -14.4% | 784,616 | +23.3% | 0.01% | 0.0% |
| Q4 2021 | $42,179,000 | -10.5% | 636,178 | -15.7% | 0.01% | -20.0% |
| Q3 2021 | $47,125,000 | -27.5% | 754,837 | -3.8% | 0.01% | -28.6% |
| Q2 2021 | $64,980,000 | +3.6% | 784,586 | -17.0% | 0.01% | -12.5% |
| Q1 2021 | $62,719,000 | -27.8% | 945,850 | -16.4% | 0.02% | -30.4% |
| Q4 2020 | $86,830,000 | +123.4% | 1,131,636 | +25.4% | 0.02% | +109.1% |
| Q3 2020 | $38,871,000 | +33.2% | 902,687 | +33.6% | 0.01% | +22.2% |
| Q2 2020 | $29,178,000 | +78.6% | 675,553 | +19.0% | 0.01% | +80.0% |
| Q1 2020 | $16,335,000 | -70.6% | 567,816 | -35.2% | 0.01% | -64.3% |
| Q4 2019 | $55,613,000 | +93.8% | 876,755 | -13.9% | 0.01% | +75.0% |
| Q3 2019 | $28,691,000 | +16.7% | 1,018,131 | +9.7% | 0.01% | +14.3% |
| Q2 2019 | $24,593,000 | +7.4% | 928,023 | -25.6% | 0.01% | 0.0% |
| Q1 2019 | $22,902,000 | +42.3% | 1,248,091 | -3.7% | 0.01% | +40.0% |
| Q4 2018 | $16,096,000 | +261.7% | 1,295,984 | +458.3% | 0.01% | +400.0% |
| Q3 2018 | $4,450,000 | +258.0% | 232,114 | +154.0% | 0.00% | – |
| Q2 2018 | $1,243,000 | -68.2% | 91,372 | -83.2% | 0.00% | -100.0% |
| Q1 2018 | $3,913,000 | +514.3% | 542,726 | +213.6% | 0.00% | – |
| Q4 2017 | $637,000 | +237.0% | 173,078 | +297.1% | 0.00% | – |
| Q3 2017 | $189,000 | -63.2% | 43,590 | -86.2% | 0.00% | – |
| Q2 2017 | $513,000 | +285.7% | 316,594 | +342.0% | 0.00% | – |
| Q1 2017 | $133,000 | -60.8% | 71,622 | -67.3% | 0.00% | – |
| Q4 2016 | $339,000 | +19.8% | 218,833 | +469.0% | 0.00% | – |
| Q3 2016 | $283,000 | +62.6% | 38,458 | +17.8% | 0.00% | – |
| Q2 2016 | $174,000 | – | 32,640 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ELEMENT CAPITAL MANAGEMENT LLC | 142,649 | $618,000 | 0.25% |
| ING GROEP NV | 808,229 | $3,500,000 | 0.07% |
| A.R.T. Advisors, LLC | 232,470 | $1,006,000 | 0.05% |
| OppenheimerFunds, Inc. | 3,000,000 | $12,990,000 | 0.02% |
| Edge Wealth Management LLC | 10,000 | $43,000 | 0.01% |
| First Allied Advisory Services, Inc. | 61,000 | $264,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 200,000 | $866,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 1,272,138 | $5,508,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 971,768 | $4,208,000 | 0.01% |
| Virtu Financial LLC | 18,008 | $78,000 | 0.00% |